Designates third full week of May of each year as "Clinical Trials Awareness Week" and May 20 of each year as "Clinical Trials Volunteers Appreciation Day" in NJ.
Impact
The resolution acknowledges the historical significance of clinical trials, tracing back to the first randomized trial conducted by British naval surgeon James Lind in 1747. Clinical trials have contributed to significant medical advancements, including the eradication of scurvy and the development of vaccines against diseases like polio and COVID-19. The Rutgers Cancer Institute and the Cooper Research Institute are highlighted as key players in advancing clinical trials in New Jersey, each conducting numerous trials to enhance treatment options for patients.
Summary
AJR96, introduced in New Jersey, designates the third full week of May as 'Clinical Trials Awareness Week' and May 20 as 'Clinical Trials Volunteers Appreciation Day.' This resolution aims to promote awareness and understanding of the critical role that clinical trials play in medical research, particularly in the development of new treatments for diseases such as cancer and the efficacy of vaccines.
Contention
One of the notable points within AJR96 is the emphasis on the contributions of clinical trials to public health and their vital role during the COVID-19 pandemic. The resolution not only seeks to honor the volunteers who participate in these trials but also calls on state officials and citizens to recognize and celebrate the importance of clinical trials through appropriate activities. This dual focus underscores the value of public engagement and understanding of medical research as a means to improve community health.
Designates third full week of May of each year as "Clinical Trials Awareness Week" and May 20 of each year as "Clinical Trials Volunteers Appreciation Day" in NJ.